News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

See how NCI researchers are working to find new ways of interpreting biopsies and managing prostate cancer. This recent model could lead to a more precise approach, reducing the need for additional and often unnecessary biopsies.

Wondering how to use AI for radiology? In a new study, NCI researchers found that AI may work best as an adjunct to the radiologist rather than a standalone solution, allowing radiologists to focus on cases that need more critical assessment.

An NCI-funded study shows that KBP models can automate radiation therapy, thereby producing high-quality plans to improve cancer treatment efficiency and reduce human workload.

Interpreting tissue biopsies may be easier using this NCI-funded tool. It features an end-to-end approach for automatically analyzing cancer cells and tissues.

NCI-funded researchers developed a new model called “SEQUOIA” that’s helping capture detailed data from whole slide images. See how this technology could someday be the solution to better biopsies.

Whether you’re researching a neoantigen, or looking to identify new therapeutic candidates, there’s a new NCI-funded tool, called “pVACview,” that may be able to help.

NCI-funded researchers are testing a new platform that blends statistical and deep learning models, giving you a fuller picture of the variants driving cancer progression.

Read this recently released collection of 13 studies to learn more about NCI’s Human Tumor Atlas Network (HTAN). You’ll gain insights into tumor development, progression, and treatment responses through advanced research methodologies and 3D tumor atlases.

Are you investigating structural variations underlying cancer-causing genes? NCI-funded researchers are testing a new algorithm that could help you track down both coding and non-coding cancer-causing genes.

Looking for new data sources for your machine learning model? NCI researchers combined data from dogs and people to identify risk factors for osteosarcoma.